Steripath Gen2 Logo Reverse

The only FDA-cleared device indicated to reduce blood culture contamination

Announcing the Steripath Gen2 product family FDA 510(k) clearance and indication to reduce blood culture contamination when contaminants are present, compared to standard method controls without diversion.

COVID-19 Support Program

We're Here to Help

We understand the challenges healthcare providers are facing with the COVID-19 pandemic and we appreciate the work they are doing to help keep our families, friends, and neighbors safe.  We want to support our customers, both current and new, by offering complimentary services and product during this time of crisis.
smiling nurse
Watch Testimonials 
Customer Success Reducing Blood Culture Contamination

Medical University of South Carolina

Steripath Clinical Results

University of Nebraska Medical Center

More About Steripath
The Problem with False Positives

False-positive blood culture results can have meaningful downstream consequences. Learn about the impact.

Read More >
The Benefits of Steripath

See how you can benefit from reducing blood culture contamination at your hospital.

Read More >
Backed by Evidence

Explore the independent clinical study results using Steripath.

Read More >
About Us

Our story, leadership, and how we came to be

Read More >
Newsroom

Company news, partnerships, press releases and events

Read More >
Patents

Explore our vast portfolio of industry innovation

Read More >